Patents by Inventor Szu-Hua Pan

Szu-Hua Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240241126
    Abstract: The present invention provides a biochip for tracking postoperative recurrence status of a patient with lung adenocarcinoma. The biochip comprises a bare plate layer, the bare plate layer comprises a sensing electrode, and the sensing electrode comprises a biological agent capable of measuring an expression amount of a GPNMB gene. The present invention further provides a method for tracking the postoperative recurrence status of a patient with lung adenocarcinoma. The method comprises the following steps: step one, providing a sample from a patient with lung adenocarcinoma; step two: contacting the sample with a carrier capable of detecting an expression amount of a GPNMB gene; and step three: analyzing a change of the expression amount of the GPNMB gene to track the postoperative recurrence status of the patient with lung adenocarcinoma.
    Type: Application
    Filed: July 14, 2023
    Publication date: July 18, 2024
    Inventors: Szu-Hua Pan, Yuan-Ling Hsu, Ching-Wen Li, How-Wen Ko, Chung-Lieh Hung
  • Patent number: 11919886
    Abstract: The present disclosure provides compounds of Formulas (I), (II), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating proliferative diseases, for example, cancer (e.g., lung cancer), and infectious diseases (e.g., bacterial infections).
    Type: Grant
    Filed: July 12, 2022
    Date of Patent: March 5, 2024
    Assignees: Academia Sinica, National Taiwan University
    Inventors: Chi-Huey Wong, Pan-Chyr Yang, Rong-Jie Chein, Szu-Hua Pan, Ting-Jen R. Cheng
  • Publication number: 20230010562
    Abstract: The present disclosure provides compounds of Formulas (I), (II), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating proliferative diseases, for example, cancer (e.g., lung cancer), and infectious diseases (e.g., bacterial infections).
    Type: Application
    Filed: July 12, 2022
    Publication date: January 12, 2023
    Inventors: Chi-Huey Wong, Pan-Chyr Yang, Rong-Jie Chein, Szu-Hua Pan, Ting-Jen R. Cheng
  • Patent number: 11434229
    Abstract: The present disclosure provides compounds of Formulas (I), (II), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating proliferative diseases, for example, cancer (e.g., lung cancer), and infectious diseases (e.g., bacterial infections).
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: September 6, 2022
    Assignees: Academia Sinica, National Taiwan UJniversity
    Inventors: Chi-Huey Wong, Pan-Chyr Yang, Rong-Jie Chein, Szu-Hua Pan, Ting-Jen R. Cheng
  • Patent number: 10765681
    Abstract: The present disclosure provides compounds of Formulas (I?) and (I), and pharmaceutically acceptable salts thereof. The compounds described herein may be useful in treating and/or preventing proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, and uses thereof for treating proliferative diseases.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: September 8, 2020
    Assignees: Academia Sinica, National Taiwan University
    Inventors: Chi-Huey Wong, Pan-Chyr Yang, Jim-Min Fang, Szu-Hua Pan, Ting-Jen R. Cheng, Ling-Wei Li
  • Publication number: 20200095233
    Abstract: The present disclosure provides compounds of Formulas (I), (II), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating proliferative diseases, for example, cancer (e.g., lung cancer), and infectious diseases (e.g., bacterial infections).
    Type: Application
    Filed: February 28, 2017
    Publication date: March 26, 2020
    Applicants: Academia Sinica, National Taiwan University
    Inventors: Chi-Huey Wong, Pan-Chyr Yang, Rong-Jie Chein, Szu-Hua Pan, Ting-Jen R. Cheng
  • Publication number: 20180369249
    Abstract: The present disclosure provides compounds of Formulas (I?) and (I), and pharmaceutically acceptable salts thereof. The compounds described herein may be useful in treating and/or preventing proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, and uses thereof for treating proliferative diseases.
    Type: Application
    Filed: February 3, 2017
    Publication date: December 27, 2018
    Applicants: Academia Sinica, National Taiwan University
    Inventors: Chi-Huey Wong, Pan-Chyr Yang, Jim-Min Fang, Szu-Hua Pan, Ting-Jen R. Cheng, Ling-Wei Li